Erik Berntorp
91 – 100 of 336
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
- Contribution to journal › Letter
-
Mark
Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
- Contribution to journal › Article
-
Mark
Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.
- Contribution to journal › Article
-
Mark
Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.
- Contribution to journal › Article
-
Mark
Introduction.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting Factor Replacement Therapy in Severe Hemophilia: Which Level Is Important?
- Contribution to journal › Article
-
Mark
Thrombin stimulates insulin secretion via protease-activated receptor-3.
- Contribution to journal › Article
-
Mark
Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.
- Contribution to journal › Article
-
Mark
Tranexamic acid - an old drug still going strong and making a revival.
- Contribution to journal › Scientific review
-
Mark
Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.
- Contribution to journal › Scientific review
